Ethanol up-regulates fatty acid uptake and plasma membrane expression and export of mitochondrial aspartate aminotransferase in HepG2 cells

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
S L ZhouPaul D Berk

Abstract

To explain the increased plasma mitochondrial aspartate aminotransferase (mAspAT) observed in alcoholics, we cultured HepG2 hepatoma cells in ethanol. Acute (24 hour) exposure to 0, 20, 40, or 80 mmol/L ethanol produced a dose-dependent (r = .98) increase in mAspAT messenger RNA (mRNA) of < or = thirteen-fold, with no significant change in the cellular content of mAspAT or of several other enzymes. The recovery of mAspAT in the medium over 24 hours of ethanol exposure correlated with both ethanol concentration and with mAspAT mRNA (r = .90), reaching 808% of cellular enzyme content/24 hours at 80 mmol/L. Recovery of all other enzymes studied was < or = 20% of cellular content and unaffected by ethanol. Plasma membrane mAspAT content also correlated with mAspAT mRNA (r = .96) and mitochondrial levels were unchanged. No mitochondrial morphologic abnormalities were observed at any ethanol concentration studied. In cells cultured chronically at 0 to 80 mmol/L ethanol, fatty acid uptake Vmax increased in parallel with plasma membrane expression of mAspAT (r = .98). Cellular triglyceride content was highly correlated with Vmax. Thus, the data suggest that: 1) the increased plasma mAspAT observed in alcoholics may reflect pharmacologi...Continue Reading

References

Nov 1, 1979·Digestive Diseases and Sciences·J A Cohen, M M Kaplan
Nov 1, 1992·Archives of Biochemistry and Biophysics·S GiannattasioE Quagliariello
Oct 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S PolR Barouki
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P D BerkS Thung
Jan 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·W SchwietermanP D Berk
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·W Stremmel, P D Berk
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·W StremmelP D Berk
Aug 13, 1987·Biochimica Et Biophysica Acta·J A ParliC D Ross
Jul 1, 1986·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·B NalpasP Berthelot
Sep 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·B NalpasP Berthelot
Sep 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·P S Thomas
Oct 10, 1995·Proceedings of the National Academy of Sciences of the United States of America·L M IsolaP D Berk
Apr 1, 1995·Journal of Molecular Evolution·C S WinefieldC J Marshall
Mar 1, 1995·Proceedings of the Society for Experimental Biology and Medicine·S L ZhouP D Berk
Dec 15, 1993·Biochemical and Biophysical Research Communications·M G NeumanC Tiribelli
Jan 1, 1994·Methods in Enzymology·C S Lieber, L M DeCarli
Oct 15, 1993·Biochemical and Biophysical Research Communications·Z M Chrzanowska-LightowlersR N Lightowlers
Nov 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S ZhouT L Wright

❮ Previous
Next ❯

Citations

Apr 16, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R A Weisiger
Mar 24, 2000·Progress in Lipid Research·B I Frohnert, D A Bernlohr
Oct 29, 2003·Journal of Pediatric Gastroenterology and Nutrition·Marianne Hørby JørgensenKim Fleischer Michaelsen
Jun 11, 2002·Annual Review of Nutrition·Tahar Hajri, Nada A Abumrad
Mar 4, 2011·The American Journal of Clinical Nutrition·Jeffrey D BrowningShawn C Burgess
Mar 8, 2014·World Journal of Gastroenterology : WJG·Maryconi M Jaurigue, Mitchell S Cappell
Apr 12, 2016·Clinics in Liver Disease·Paul D Berk, Elizabeth C Verna
Mar 13, 2009·Progress in Lipid Research·Isabelle NiotPhilippe Besnard
Oct 31, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Paul D Berk
Jun 3, 2004·The Journal of Surgical Research·Shinichiro UchinoMichio Ogawa
Aug 28, 2004·Clinics in Liver Disease·Michael W Bradbury, Paul D Berk
Nov 28, 2013·Journal of Lipid Research·Robin D ClugstonLi-Shin Huang
Sep 18, 2002·Journal of Lipid Research·Jürgen PohlWolfgang Stremmel
Jun 4, 2020·Cancers·Moris SanginetoGaetano Serviddio
Jan 28, 2015·World Journal of Gastroenterology : WJG·Silvia Sookoian, Carlos J Pirola
Jan 13, 2006·American Journal of Physiology. Gastrointestinal and Liver Physiology·Michael W Bradbury
Dec 1, 2019·Liver Research·Ryan J Schulze, Wen-Xing Ding
Jul 21, 2020·Translational Research : the Journal of Laboratory and Clinical Medicine·Mohamed Tausif Siddiqui, Gail A M Cresci

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.